💥Join UPSC 2027,2028 Mentorship (July Batch) + XFactor Notes & Microthemes PDF
Talk to Mentor

Civilsdaily

Login

Subject: Social Justice

  • Tax ‘HFSS’ foods, view it as a public health imperative

    LocalCircles Survey: 79% citizens in favour of tax on high fat, sugar and salty (HFSS) foods

    Central idea 

    The article advocates for the immediate implementation of High Fat Sugar Salt (HFSS) taxes in India to tackle health risks, emphasizing their role in encouraging healthier choices, driving industry reformulation, and reducing the economic strain on healthcare. It positions HFSS taxation as a vital public health imperative to address market failures and promote a sustainable food system.

    Key Highlights:

    • Rising Health Risks: High Fat Sugar Salt (HFSS) foods contribute significantly to health issues like obesity, diabetes, and high blood pressure. The global burden of Non-Communicable Diseases (NCDs) in India has surged from 38% in 1990 to 65% in 2019, with 1.2 million deaths annually attributed to dietary risks.
    • Economic Impact: Overweight and obesity’s economic impact in India was estimated at $23 billion in 2017, expected to rise to $480 billion by 2060. The ultra-processed food sector in India grew at a compounded annual growth rate of 13.4% between 2011 and 2021.
    • Global Trend of Taxation: Many countries, including Denmark, France, Hungary, Mexico, South Africa, the UK, and the US, have implemented taxes on HFSS foods to combat obesity. Colombia’s recent “junk food law” serves as a model for other nations.
    • Market Failures and Externalities: The consumption of HFSS foods leads to negative externalities in the form of increased healthcare expenditures, imposing societal costs. Taxes are proposed as a targeted tool to curb detrimental consumption habits, reducing societal burdens.
    • Need for HFSS Tax: The article argues for taxing HFSS due to market failures, negative externalities, and internalities. Unlike sin goods, HFSS taxation aims to incentivize the industry to reformulate products for healthier alternatives and prompt consumers to choose a healthier diet.
    • Designing Effective HFSS Tax: Properly designed HFSS taxes can be non-regressive and fiscally neutral. Differentiated tax rates based on nutritional quality can incentivize product reformulations. The goal is to make healthier alternatives more affordable and accessible.
    • Inconsistencies in GST Rates: Current GST rates on ultra-processed foods do not align with nutritional content. Uniform tax rates overlook variations in sugar, salt, and nutritional impact, limiting their impact on altering consumption patterns.
    • Public Health Imperative: HFSS taxation is positioned not just as an economic or fiscal policy concern but as a public health imperative. Effective taxes, combined with nutrition literacy and food labeling, can combat overweight and obesity, fostering a more sustainable and equitable food system.

    Key Challenges:

    • Resistance from Industry: The food industry may resist HFSS taxes, viewing them as detrimental to profits. Balancing industry interests with public health objectives poses a challenge.
    • Designing Optimal Tax Rates: Determining the right tax rates that effectively deter HFSS consumption without being regressive requires careful consideration and analysis.
    • Consumer Awareness: Ensuring that consumers are aware of the health implications of HFSS foods and understand the purpose of taxes is crucial for the success of such interventions.

    Key Terms/Phrases:

    • HFSS Foods: High Fat Sugar Salt foods, known for their negative impact on health.
    • Negative Externalities: Detrimental effects of HFSS consumption on society, leading to increased healthcare costs.
    • Internalities: Harm caused to individuals due to limited understanding influenced by marketing.
    • Market Failures: Situations where the market does not efficiently allocate resources, leading to suboptimal outcomes.
    • Non-regressive Tax: A tax that does not disproportionately burden lower-income individuals.
    • Nutritional Quality: The nutritional content and health impact of food products.

    Key Quotes:

    • “HFSS taxation in India should not be merely seen as an economic or fiscal policy concern but it deserves to be considered a public health imperative.”
    • “Effectively designed taxes can reap multiple benefits — they can act as a deterrent to consuming HFSS; promote healthier food choices; prompt manufacturers to reformulate foods; improve public health outcomes…”

    Key Statements:

    • “The imperative for taxing HFSS arises from significant market failures associated with their consumption, contributing to negative externalities and internalities.”
    • “HFSS taxation in India should be both non-regressive and fiscally neutral, creating a level-playing field between HFSS and their healthier alternatives.”

    Critical Analysis:

    The article provides a comprehensive overview of the health and economic challenges associated with HFSS consumption in India. It effectively argues for the implementation of HFSS taxes as a public health imperative and highlights the need for well-designed, non-regressive tax policies. The emphasis on creating a fiscal environment that incentivizes healthier choices and product reformulation adds depth to the analysis.

    Way Forward:

    • Collaborative Approach: Engage stakeholders, including the food industry, health professionals, and policymakers, to collaboratively design and implement effective HFSS tax policies.
    • Continuous Evaluation: Regularly assess the impact of HFSS taxes on consumption patterns, health outcomes, and industry practices, making adjustments as needed.
    • Public Awareness Campaigns: Launch campaigns to educate the public about the health risks associated with HFSS foods and the purpose of taxation, fostering informed choices.
    • International Best Practices: Learn from and adapt successful strategies from countries that have effectively implemented HFSS taxes to address obesity and improve public health.
    • Research and Innovation: Encourage research on the nutritional content of food products and innovative ways to reformulate HFSS items for healthier alternatives.

  • Kidney Transplants in India: Law, Demand and Alleged Rackets

    Kidney Transplants

    Central Idea

    • The government has initiated an investigation into allegations that poor villagers from Myanmar were coerced into selling their kidneys to wealthy patients, with Delhi’s Apollo hospital implicated in the scheme.

    India’s Transplant Law and Kidney Scams

    • India’s Transplantation Law: The Transplantation of Human Organs and Tissues Act, 1994, in India allows organ donations from living persons, primarily close relatives, and deceased donors.
    • Curb on organ trade: It strictly prohibits organ trade to prevent exploitation of the poor.
    • Previous Allegations: This isn’t the first instance of alleged kidney scams in India, with most rackets reportedly using forged documents to establish fake donor-recipient relationships.

    Procedure for Legal Transplants

    • Documentation for Close Relatives: For living donations involving close relatives, both Indian and foreign nationals must submit identity proofs, family trees, relationship evidence, and financial status documents.
    • Scrutiny for Unrelated Donors: Donations from non-relatives require additional evidence of long-term association and undergo rigorous examination by an external committee to prevent illegal transactions.
    • Penalties for Illegal Organ Trade: The law imposes severe punishments, including imprisonment and hefty fines, for any involvement in organ trade or related illegal activities.

    Kidney Transplants: High Demand and Target for Illegal Trade

    • High Demand: Approximately 2 lakh Indians annually reach end-stage kidney failure, necessitating transplants or dialysis, but only about 12,000 transplants occur each year.
    • Low Risk and Accessibility: Kidney transplants pose the least risk to donors and are relatively affordable and widely available in India, making kidneys a common target for illegal trade.
    • Organ Viability: Kidneys can survive outside the body for 24-36 hours, longer than lungs or liver, increasing their viability for transplants.

    Addressing the Organ Supply Gap

    • Promoting Deceased Donations: Increasing awareness and promoting donations from brain-dead individuals can significantly enhance the organ pool.
    • Government Initiatives: The government has introduced an Aadhaar-linked donor registry to encourage deceased donations, which currently constitute only 16% of total transplants in India.
    • Reducing Transplant Necessity: Efforts are also needed to decrease the number of people requiring organ transplants.

    Conclusion

    • Combating Illegal Organ Trade: The ongoing investigation into the alleged kidney racket highlights the need for stringent vigilance and adherence to legal procedures in organ transplants.
    • Enhancing Legal Organ Donation: Increasing public awareness and promoting legal avenues for organ donation are crucial steps in addressing the organ supply-demand gap and preventing exploitation in organ trade.

  • The future of healthcare is in our genes

    Gene Therapy Products: Separate Regulations? - BioProcess InternationalBioProcess International

    Central idea 

    The article underscores the transformative potential of gene and cell therapy in addressing India’s healthcare challenges, particularly genetic disorders, cancer, and infectious diseases. It emphasizes the imperative for a paradigm shift, highlighting the need for collaborative efforts, regulatory frameworks, and increased awareness to integrate these therapies into mainstream healthcare.

    Key Highlights:

    • Genetic Disorders in India: Over 40 million individuals in India suffer from genetic disorders, emphasizing the urgent need for advanced treatments like gene therapy.
    • Haemoglobinopathies: Conditions like Thalassemia and Sickle Cell Anaemia affect millions, and gene therapy offers a potential cure by addressing the root genetic mutations.
    • Cancer Treatment: With 1.16 million new cancer cases annually, gene and cell therapy, especially CAR-T therapy, present precision medicine solutions tailored to individual genetic profiles.
    • Infectious Diseases: Gene therapy shows promise in treating infectious diseases, including potential applications against viral threats like dengue, HIV/AIDS, and others.
    • Future Vision: Gene and cell therapies anticipate a future of precise and personalized treatments, reducing economic burdens associated with chronic conditions.

    Key Challenges:

    • Infrastructure Limitations: Integrating gene and cell therapy into mainstream healthcare faces challenges related to infrastructure readiness.
    • Ethical Considerations: The ethical implications of gene therapy, including issues of consent and long-term consequences, pose challenges to widespread adoption.
    • Awareness Gap: Limited awareness among healthcare professionals and the public about gene and cell therapy hinders successful integration.

    Key Terms and Phrases:

    • Precision Medicine: Tailored medical approaches considering the unique genetic makeup of each patient.
    • Chimeric Antigen Receptor T-cell therapy (CAR-T): Modifying a patient’s immune cells to target cancer cells, exemplifying precision medicine.
    • mRNA Vaccines: Groundbreaking gene-therapy products, as seen in Covid-19 vaccines like Pfizer-BioNTech and Moderna.
    • Severe Combined Immunodeficiency (SCID): A genetic disorder potentially treatable with gene therapy to restore normal immune function.

    Key Quotes:

    • “Gene therapy is not just about managing symptoms — it is about rewriting the genetic code that underlies these conditions.”
    • “The imperative lies in investing in research and infrastructure to make these transformative therapies accessible to those who need them.”
    • “Gene and cell therapy are not just treatments; they are the future of healthcare.”

    Key Examples and References:

    • Haemoglobinopathies Impact: Thalassemia and Sickle Cell Anaemia affecting 40 million individuals in India.
    • Cancer Cases: Over 1.16 million new cancer cases annually, highlighting the demand for advanced treatments.
    • mRNA Vaccines: Pfizer-BioNTech and Moderna Covid-19 vaccines as groundbreaking gene-therapy products.

    Key Facts and Data:

    • Demographic Impact: Genetic disorders affect millions in India, necessitating advanced treatments.
    • Cancer Statistics: Over 1.16 million new cancer cases reported annually in India.
    • Economic Burden: Gene therapy’s potential to reduce long-term healthcare costs for chronic genetic conditions.

    Critical Analysis:

    • Integration Challenges: Infrastructural and ethical challenges pose hurdles to the mainstream integration of gene and cell therapy.
    • Opportunities for Collaboration: Challenges present opportunities for collaborative efforts among scientific communities, industries, policymakers, and healthcare providers.
    • Need for Awareness: Limited awareness emphasizes the importance of enhancing awareness among healthcare professionals and the public for successful integration.

    Way Forward:

    • Collaborative Efforts: Encourage collaboration between scientific communities, industries, policymakers, and healthcare providers to overcome challenges.
    • Regulatory Frameworks: Develop regulatory frameworks balancing innovation with ethical considerations to guide gene therapy integration.
    • Research and Development: Invest in research and development to advance gene and cell therapy, addressing infrastructure limitations and ethical concerns.
    • Public Awareness: Foster awareness among healthcare professionals and the public to ensure successful integration into the broader healthcare landscape.

  • Advisory issued against drug ‘Meftal’

    Central Idea

    • Pharma standard body Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert for commonly used painkiller mefenamic acid, popularly sold under the brand name Meftal.

    What is Meftal used for?

    • Meftal 500, a non-steroidal anti-inflammatory drug (NSAID) is usually prescribed in treatment for conditions like menstrual pain, headache, muscle, joint, or dental pain.
    • It has been advised to take the table with food.
    • The most common side effects of the medicine include mild vomiting, stomach pain, nausea, headache, and dizziness.

    What does the alert against Meftal say?

    • IPC stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome.
    • DRESS, also known as drug induced hypersensitivity syndrome, is an adverse drug reaction that can even be life threatening.
    • It may cause damage to several organs, especially to the kidneys, heart, lungs, and pancreas.
    • The mortality rate is high and is about 10 per cent.

    Back2Basics: Indian Pharmacopoeia Commission (IPC)

    Details
    Establishment 1956,

    An autonomous body under the Ministry of Health and Family Welfare
    Primary Objective To promote public health by setting and updating standards for drug quality in India.
    Key Publication Indian Pharmacopoeia (IP), a legally recognized book of drug standards.
    Role in Drug Regulation Standards set in the IP are enforceable by law, crucial for India’s drug regulatory framework.
    International Recognition Collaborates with WHO and aligns with global drug standards.
    Pharmacovigilance Program Involved in monitoring and analyzing adverse drug reactions through the PvPI.
    Quality Control & Training Engages in drug quality control and provides training to regulatory bodies and the pharmaceutical industry.
    Publication Updates Periodically updates the IP to include new drugs and revise existing standards.
    Collaboration Works with the pharmaceutical industry, academia, and regulatory bodies.
    Global Harmonization Aims to harmonize the IP with international pharmacopoeias like the USP and BP.

  • India’s alarming ‘fixed dose combination’ problem

    Antimicrobial resistance is rising in India, says ICMR report | Mumbai News - Times of India

    Central idea 

    The study reveals a startling prevalence of unapproved and banned Fixed Dose Combinations (FDCs) of antibiotics in India, posing risks of antimicrobial resistance. The pharmaceutical industry’s exploitation of FDCs to evade regulations, coupled with regulatory inefficiencies, calls for urgent interventions to safeguard public health

    Key Highlights:

    • Alarming Prevalence: In 2020, 60.5% of antibiotics in India were unapproved FDCs, with an additional 9.9% banned, raising concerns about antimicrobial resistance.
    • Patient Compliance vs. Risks: FDCs, aimed at improving patient adherence, pose risks due to potential interactions between combined drugs, necessitating a stringent approval process.
    • Pharmaceutical Industry’s Strategy: Exploitation of FDCs allows the industry to evade drug price regulations, contributing to the proliferation of irrational combinations.

    Key Challenges:

    • Regulatory Framework Inefficiency: Continued sale of unapproved FDCs highlights regulatory inefficiency, allowing non-compliance despite existing legal provisions.
    • Reactive Regulatory Measures: Reliance on Section 26A orders reveals a reactive rather than proactive regulatory approach, indicating systemic challenges.

    Key Terms:

    • Fixed Dose Combination (FDC): Combinations of multiple drugs in a single dosage form, potentially affecting drug interactions and therapeutic efficacy.
    • Antimicrobial Resistance (AMR): The ability of microorganisms to resist the effects of medications, posing a global health threat.

    Key Phrases:

    • Pharmaceutical Industry’s Exploitation: The strategic use of FDCs to avoid regulatory scrutiny undermines the integrity of drug pricing and quality.
    • Ineffectiveness of Regulatory Measures: Despite legal provisions, the regulatory system relies on reactive prohibitions rather than proactive prevention.

    Key Quotes:

    • “Unapproved FDCs may contribute to the AMR problem in India.”
    • “The pharmaceutical industry gets to provide its own standards for government testing of FDCs.”

    Key Statements:

    • Extent of the Issue: The study underscores the alarming prevalence of unapproved and banned FDCs in India, emphasizing the urgent need for regulatory intervention.
    • Industry Motives: The article critically examines the pharmaceutical industry’s profit-driven motives, exposing the imbalance between pseudo-innovation for profit and genuine drug development.
    • Regulatory Challenges: Scrutiny of regulatory challenges and legal inconsistencies indicates a systemic failure in ensuring the safety and efficacy of pharmaceutical products.

    Key Examples and References:

    • Academic Study: Reference to the academic study published in the Journal of Pharmaceutical Policy and Practice (2023) highlighting the extent of unapproved FDCs.
    • Historical Context: Tracing the issue back to 1978 and subsequent regulatory amendments provides context to the ongoing challenges.

    Critical Analysis:

    • Industry Practices: The article critically examines the pharmaceutical industry’s motives, highlighting the imbalance between pseudo-innovation for profit and genuine drug development.
    • Regulatory Challenges: Scrutiny of regulatory challenges and legal inconsistencies indicates a systemic failure in ensuring the safety and efficacy of pharmaceutical products.

    Way Forward:

    • Urgent Regulatory Actions: Emphasizes the need for regulatory actions to address the menace of unapproved and banned FDCs, preventing potential contributions to antimicrobial resistance.
    • Proactive Regulatory Framework: Calls for a proactive regulatory framework that prioritizes public health over industry interests and plugs existing legal loopholes.

  • Invisible Indians – sex workers, bar dancers, trans men and women – and lessons for AIDS epidemic

    Overview: Living Conditions of Sex-Workers in India — Ylcube

    Central idea

    The article on World AIDS Day sheds light on the neglected lives of Mumbai’s marginalized communities, emphasizing lessons from the HIV epidemic. It calls for grassroots engagement, holistic healthcare solutions, and dignity-centered public health strategies.

    Key Highlights:

    • Forgotten Narratives: Reflecting on the lives of marginalized communities in Mumbai on World AIDS Day.
    • Overlooked Wisdom: Emphasizing the resilience of sex workers, bar dancers, and trans individuals.
    • Lessons from the Epidemic: Drawing insights from the HIV epidemic and its impact on these communities.

    Key Challenges:

    • Information Gap: Sub-standard public awareness efforts leading to misinformation.
    • Access Barriers: Discrimination preventing vulnerable communities from accessing healthcare.
    • Top-Down Struggles: Ineffectiveness of top-down approaches in understanding diverse high-risk communities.

    Key Terms:

    • Grassroots Engagement: Involving local communities in decision-making and solutions.
    • Holistic Solutions: Addressing issues comprehensively, considering social, economic, and cultural contexts.
    • Stigma and Discrimination: Negative attitudes and actions directed towards marginalized groups.

    Key Phrases:

    • “Forgotten Narratives“: Bringing attention to the overlooked stories of marginalized communities.
    • “Grassroots Wisdom”: Advocating for effective health interventions through community involvement.
    • “Holistic Approach”: Moving beyond traditional health services for comprehensive solutions.

    Key Examples and References:

    • Walks in Mumbai’s Shadows: Personal anecdotes from journeys with marginalized groups.
    • Voices of Resilience: Quotes sharing insights on life, disease, and discrimination.
    • Epidemic Lessons: Reference to valuable knowledge gained during the HIV epidemic.

    Experts Warn of a Return of the AIDS Epidemic

    Key Facts:

    • Call for Collective Action: Emphasizing the need for public trust and stakeholder involvement.
    • Investment in Health: Recognizing the commitment of poor and vulnerable populations to their well-being.
    • Activism’s Role: Highlighting activism as essential for equitable and accessible healthcare.
    Key Quotes, Anecdotes, Key Statements for good marks
     
    “Even the best strategies falter without grassroots engagement.”
    “The key to ending an epidemic lay in uniting diverse high-risk groups, combating stigma and discrimination.”
    “Conversations with these communities illuminated the multidimensional aspects of human sexuality, desire, and behavior change.”
    “Every issue had human, economic, and social dimensions.”
    “Activism is the kernel around which change can grow. In India, even today, marginalized groups face mistreatment, and it is activism that can make care equitable and accessible.”
    “Health must come with dignity and empowerment.”
    “They certainly gave me life lessons in self-respect, desire, and love.”

    Critical Analysis:

    • Emotional Impact: Personal anecdotes and quotes enhance the emotional connection to the narrative.
    • Advocacy for Change: Effectively advocates for a shift towards inclusive, grassroots-centered health strategies.
    • Learnings from Marginalized: Stresses the importance of learning from marginalized communities for effective healthcare solutions.

    Way Forward:

    • Dignity-Centered Strategies: Calls for strategies prioritizing dignity, equity, and grassroots engagement.
    • Community Learning: Emphasizes the value of understanding and incorporating lessons from marginalized communities in public health interventions.

     

  • [pib] Ayurveda Gyan Naipunya Initiative (AGNI)

    Central Idea

    • The Central Council for Research in Ayurveda Sciences (CCRAS), under the Ministry of Ayush, has introduced the “Ayurveda Gyan Naipunya Initiative” (AGNI) to promote research and innovation among Ayurveda practitioners.

    Ayurveda Gyan Naipunya Initiative

    • AGNI aims to document and validate Ayurvedic medical practices, enhance evidence-based practice culture, and facilitate scientific research in the field.
    • It provides a platform for Ayurveda practitioners to share their innovative practices, fostering an evidence-based culture.
    • It also supports research to validate pragmatic Ayurvedic practices through scientific methods.

    Key functions

    • CCRAS will document and publish reported medical practices and therapeutic regimens for educational and academic purposes in consultation with the National Commission for Indian System of Medicine (NCISM).
    • AGNI provides a platform for Ayurveda practitioners to report their innovative practices and experiences across various disease conditions.
    • The initiative encourages the culture of evidence-based practice among Ayurveda practitioners, ensuring that their methods are grounded in scientific research.
    • AGNI seeks to identify interested Ayurveda practitioners willing to collaborate in creating a comprehensive database through applications.
    • Capacity building through research methods and good clinical practice training will also be offered.
    • AGNI will undertake research to mainstream pragmatic Ayurvedic practices through scientific validation and evidence-based appraisal.

  • Mosquitofish: India’s Battle against Invasive Species

    Mosquitofish

    Central Idea

    • In recent months, Indian states such as Andhra Pradesh, Odisha, and Punjab have introduced mosquitofish to combat mosquito infestations.
    • However, the unintended ecological consequences of introducing this invasive species have raised concerns.

    Backgrounder: Vector Borne Diseases

    • Global Mosquito-Borne Disease Prevalence: Mosquito-borne diseases affect over 150 countries and 500 million people worldwide.
    • India’s Burden: India alone reports approximately 40 million cases of mosquito-borne diseases annually.

    What is Mosquitofish?

    • Introduction in the 1960s: In the 1960s, biological control methods were adopted to combat mosquitoes, including the introduction of mosquitofish (Gambusia species).
    • Environmental Alternatives: These methods were considered environmentally friendly alternatives to chemical pesticides, which posed health and environmental risks.
    • Global Proliferation: Mosquitofish, originally from the U.S., have now become widespread globally, adapting to various environments with adverse ecological impacts.

    Mosquitofish in India

    • Historical Introduction: In 1928, Gambusia was introduced in India during British rule, mainly for malaria control.
    • Multiple Authorities Involved: Various governmental and private organizations, including the Indian Council of Medical Research (ICMR), National Institute of Malaria Research (NIMR), municipal corporations, and health departments, introduced mosquitofish across India.

    Ecological Impact

    • Invasive Alien Species: Mosquitofish are considered among the hundred most detrimental invasive alien species.
    • Negative Effects: They prey on native fauna, leading to the extinction of native fish, amphibians, and freshwater communities.
    • Examples from Other Countries: Australia and New Zealand have reported similar ecological harm due to introduced mosquitofish.
    • WHO’s Stand: The World Health Organization stopped recommending Gambusia for mosquito control since 1982.

    Current Situation and Recommendations

    • Enforcement Measures: Stringent enforcement measures are essential to prevent further introduction of mosquitofish and mitigate past introductions’ consequences.
    • Alternative Solutions: Collaboration between mosquito biologists, entomologists, invasion ecologists, and fish taxonomists is suggested to identify native fish species capable of controlling mosquito larvae.
    • Local Solutions: Local alternatives should be favored over invasive species to preserve indigenous aquatic biodiversity and native species’ well-being.
    • National Centre for Vector Borne Diseases Control (NCVBDC): The NCVBDC should remove its recommendation for the use of Gambusia and Poecilia (guppy) fishes for mosquito control.

    Conclusion

    • India faces a pressing ecological challenge with the unintended consequences of mosquitofish introduction.
    • To safeguard the environment and native species, stringent enforcement and local solutions should replace invasive species in mosquito control efforts.

  • Making public education inclusive

    Practising inclusive education in India: Taking the agenda forward – Cambridge Network for Disability and Education Research (CaNDER). © All Rights Reserved.

    Central idea

    Odisha revolutionizes public education with initiatives like Odisha Adarsha Vidyalayas, ‘Mo School’ Abhiyan, and 5T-High School Transformation, aiming to surpass private schools in quality. This results in a substantial shift, with 81% of students currently enrolled in government schools. The state’s commitment to inclusivity, alumni engagement, and technology integration drives equality and excellence in education.

    Key Highlights:

    • Revolutionary Reforms: Odisha’s education sector undergoes revolutionary changes through initiatives like Odisha Adarsha Vidyalayas, ‘Mo School’ Abhiyan, and 5T-High School Transformation Programme.
    • Recognition and Ranking: OAVs receive accolades, with one ranked the fifth-best in government-run day schools, emphasizing qualitative English-medium education for rural and semi-urban areas.
    • Inclusive Enrollment: OAVs ensure representation of marginalized groups, leading to a higher enrollment of female students. They also rescue and prepare vulnerable children for OAV entrance exams.
    • Alumni Engagement: Mo School Abhiyan connects schools with alumni, promoting mentorship, collaboration, and financial contributions, creating a significant impact on infrastructure and engagement.

    Key Phrases:

    • Quality Education: Odisha’s focus on continuous teacher education, technology integration, and maintaining a favorable teacher-pupil ratio highlights its commitment to providing quality education.
    • Alumni Community: Mo School Abhiyan leverages the alumni community to contribute to school development, creating a unique model of collaborative efforts for educational improvement.
    • 5T-High School Transformation: The 5T concept drives the High School Transformation Programme, emphasizing transparency, technology, teamwork, and timeliness for comprehensive educational changes.

    UNFPA India | Empowering Adolescents in Odisha through Life Skills Education

    Analysis:

    Odisha’s proactive approach to education, combining infrastructure development, alumni engagement, and technology integration, has led to a significant shift in enrollment patterns, with a majority of students now choosing government schools.

    Key Data:

    • Enrollment Shift: In 2019-20, private schools had 16,05,000 students; in 2021-22, this number reduced to 14,62,000, indicating a shift towards government schools.
    • Financial Contributions: More than 5.5 lakh contributors, including ministers, MPs, and professionals, have contributed over ₹797 crore in 40,855 schools under the School Adoption Programme.

    Key Terms:

    • Odisha Adarsha Vidyalayas (OAV): A model aiming to bridge the rural-urban education gap by providing qualitative and affordable English-medium education.
    • Mo School Abhiyan: An initiative connecting schools with alumni, promoting collaboration, contributions, and celebrating successes to improve government schools.
    • 5T-High School Transformation Programme: Rooted in transparency, technology, teamwork, and timeliness, focusing on technological advancements and holistic development in high schools.

    Challenges:

    • Parental Trust: Historical perceptions of poor education quality in government schools challenge rebuilding parental trust.
    • Affordability Concerns: Despite reforms, concerns persist regarding the economic accessibility of quality education in government schools.
    • Perceived Quality Gap: Overcoming the perception gap regarding the quality of education in government schools compared to private counterparts.
    • Economic Accessibility: Addressing financial barriers for families, ensuring that quality education remains economically accessible.

    Way Forward:

    • Continuous Alumni Engagement: Strengthen collaborations between schools and alumni to maintain a sustained focus on improvement. Explore mentorship programs and alumni-led initiatives for ongoing school development.
    • Enhancing Perceived Value: Implement awareness campaigns highlighting the positive changes in government schools. Showcase success stories and academic achievements to alter perceptions.
    • Financial Inclusivity: Introduce scholarship programs or financial aid to address economic barriers. Collaborate with governmental and non-governmental organizations to provide educational subsidies.
    • Technology Integration: Expand technological resources in schools for interactive and enhanced learning experiences. Introduce digital literacy programs to prepare students for a technology-driven future.

  • Branded, generic and the missing ingredient of quality

     

    What are Generic Medicines and why are they affordable?

    What is the news?

    Following the Indian Medical Association’s protest, the NMC has withdrawn the order on ‘generic prescribing’ since August 23, 2023

    Central idea

    The article highlights challenges in India’s healthcare system, emphasizing the struggle between generic and brand prescriptions. It discusses the alleged nexus between pharmaceutical companies and doctors, quality assurance concerns, and the need for comprehensive measures to ensure affordable and reliable access to medicines. The withdrawal of the generic prescribing order reflects ongoing complexities in achieving universal healthcare goals.

     

    Key Highlights:

    • Over-the-Counter Medical Sales in India: Patients often seek second opinions from non-qualified individuals in medical shops, with queries ranging from medicine strength to potential side effects.
    • Generic vs. Brand Names: The National Medical Council (NMC) directed doctors to prescribe generic names over brand names, emphasizing the cost factor and the affordability of generic names. The Hathi Committee in 1975 supported the gradual phasing out of brand names.
    • Alleged Nexus and Ethical Commitment: An alleged nexus between pharmaceutical companies and doctors exists, but medical associations stress their ethical commitment to improving access to affordable medicines.
    • Quality Assurance Concerns: Concerns about the quality of medicines persist, with a prevalence rate of 4.5% for spurious and 3.4% for “not standard quality” medicines. The need for 100% quality-tested drugs is crucial for patient safety.
    • Government’s Role: The government is urged to ensure quality through Universal Health Coverage and private healthcare networks, with calls for periodic sampling, banning batches that fail quality tests, and taking punitive actions against manufacturers.

    Challenges:

    • Quality Assurance Implementation: Existing mechanisms for quality assurance are not earnestly implemented, raising concerns about the reliability of the system.
    • Enforcement of Generic Prescription: The moral dilemma in enforcing generic prescription without concrete evidence of standard quality poses a challenge in the healthcare system.
    • Availability of Essential Medicines: The low availability rate of essential medicines, especially pediatric medicines, hampers the effective treatment of patients.
    • Unscientific Combinations: The presence of unscientific combinations of medicines in the retail market adds complexity to the pharmaceutical landscape.

    Analysis:

    • Role of the Chemist: Concerns revolve around the chemist or less knowledgeable salesperson determining the brand, potentially based on profit motives, impacting the choice of medicines.
    • Withdrawal of Generic Prescription Order: The withdrawal of the NMC order on generic prescribing, following the Indian Medical Association’s protest, reflects the ongoing challenges in healthcare policy.
    Case study to improve answer quality

    The Tamil Nadu Medical Services Corporation Limited’s practice, where all supplied medicines are kept under quarantine stock till double blinded samples are cleared in quality testing by government and private sector laboratories, is worth replicating.

    Key Data:

    • Prevalence of Spurious and NSQ Medicines: National drug surveys in the last 10 years indicate prevalence rates of 4.5% for spurious and 3.4% for “not standard quality” medicines, highlighting the need for stricter quality control.
    • Availability of Essential Pediatric Medicines: A study in Chhattisgarh in 2010 found only a 17% availability rate of essential pediatric medicines, indicating a significant gap in accessibility.

    Way Forward:

    • Government Assurance and Evidence: The government should provide concrete evidence of the standard quality of medicines before enforcing generic prescriptions, ensuring patient safety.
    • Comprehensive Measures: Implementing comprehensive measures, such as limiting profit margins for wholesale and retail agents, is crucial for creating a transparent and fair pharmaceutical ecosystem.
    • Janaushadhi Kendras Expansion: Expanding the network of Janaushadhi kendras is essential to improve accessibility to affordable medicines and promote their widespread availability.
    • Monitoring Implementation: Ensuring proper implementation and monitoring of policies for free medicines and diagnostics under Universal Health Care is vital for the success of healthcare initiatives.
    • Addressing Profit Motives: Addressing profit motives influencing the choice of medicines by chemists and salespersons is essential for a patient-centric healthcare system.

    Conclusion:

     

    The withdrawal of the generic prescribing order is seen as a step back in achieving universal access to affordable generic medicines. Addressing quality concerns, ensuring availability, and monitoring implementation are crucial for a successful healthcare system.